MNSBMainStreet Bancshares, Inc.
The schedule
- Mon19Oct
Q3 print focusing on deposit stability, yield cost, and forward guidance for the remainder of the fiscal year.
- Sat5Dec
End-of-year corporate updates detailing potential share buybacks or dividend strategy adjustments for 2027.
- Mon18Jan
- Mon15Feb
The 10-K release introduces severe regulatory scrutiny on MNSB's loan book, non-performing assets, and CRE footprint.
- Mon19Apr
Initial 2027 quarterly results evaluating springtime loan origination velocity and early fiscal trajectory.
Past
- Tue15Sep
The September Fed decision brings regional bank net interest margins and Commercial Real Estate (CRE) exposure to the forefront.
- Mon20Apr
Actual outcome: Bull · $24.75 at outcome
MainStreet Bancshares reported Q1 2026 earnings of $0.48 per share, beating consensus estimates of $0.45 and demonstrating strong year-over-year growth. This solid bottom-line performance, coupled with a subsequent analyst upgrade to a 'Buy' rating, validated the bank's ability to defend its profitability and drove the stock past the $24.00 bull target shortly after the release.
Q2 2026 earnings on April 20 will show Q1 2026 net interest margin trends and deposit betas, testing whether MainStreet Bancshares can defend profitability at a $23.06 share price that already sits at a 52-week high.
- Sun1Mar
Actual outcome: Bull · $22.16 at outcome
MainStreet Bank's strategic expansion into Middleburg, Virginia, signaled operational confidence and a focus on high-wealth community banking, which offset previous anxieties regarding credit exposure and insider selling. This growth-oriented move helped the stock reach and exceed the $22.00 bull target by the outcome date, as investors prioritized the bank's physical footprint expansion over short-term fundamental concerns.
Despite low net charge-offs, high classified assets (2.69%) and non-accruals (1.69%) from the Q4 2025 report, coupled with 6 insider sell transactions, create immediate bearish sentiment. A price drift toward the lower end of the recent 52-week range is likely as risk-averse investors sell into the fundamental weakness.
